Articles by Erin Slifka

GSK extended its collaboration with Zhifei to commercialize its shingles vaccine Shingrix in China until 2034.

Global insured losses from natural catastrophes like hurricanes and floods are on track to exceed $135 billion in 2024, marking the fifth consecutive year with such losses surpassing the $100-billion mark, the Swiss Re Institute said.

The Competition and Markets Authority said the deal will likely boost competition in the U.K. mobile sector, but would only proceed if both companies implement certain conditions.

While the off-road-vehicle maker Polaris has benefited from moving some production south, Trump’s levy proposal is primed to add millions in costs.

The cuts amount to around 5% of the division’s workforce, fewer than the up to 2,500 positions Airbus had initially sought to eliminate two months ago.

The Ministry of Industry and Trade asked Temu to cease sales in the country until a licensing process is completed, state media reported Thursday.

The e-commerce company named Charles Baker as its next CFO, effective Jan. 1. He succeeds Rachel Glaser, whose retirement was announced in late July.

The U.K. sports-fashion retailer lost $540.4 million off its market value after it lowered expectations for its fiscal year, citing recent tough business conditions and weak consumer confidence.

People who advise companies on security issues say threats against executives are rising.

Safran anticipates further sales and profit growth next year and said it intends to return about 70% of its cash generation to shareholders from 2025 to 2028.